These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9456002)

  • 1. N-alkylated derivatives of [D-Pro10]dynorphin A-(1-11) are high affinity partial agonists at the cloned rat kappa-opioid receptor.
    Soderstrom K; Choi H; Berman FW; Aldrich JV; Murray TF
    Eur J Pharmacol; 1997 Nov; 338(2):191-7. PubMed ID: 9456002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and opioid activity of [D-Pro10]dynorphin A-(1-11) analogues with N-terminal alkyl substitution.
    Choi H; Murray TF; DeLander GE; Schmidt WK; Aldrich JV
    J Med Chem; 1997 Aug; 40(17):2733-9. PubMed ID: 9276018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N,N-diallyl-tyrosyl substitution confers antagonist properties on the kappa-selective opioid peptide [D-Pro10]dynorphin A(1-11).
    Gairin JE; Mazarguil H; Alvinerie P; Botanch C; Cros J; Meunier JC
    Br J Pharmacol; 1988 Dec; 95(4):1023-30. PubMed ID: 2905908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of arodyn, a novel acetylated kappa opioid receptor antagonist.
    Bennett MA; Murray TF; Aldrich JV
    J Pept Res; 2005 Mar; 65(3):322-32. PubMed ID: 15787962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynorphin-selective inhibition of adenylyl cyclase in guinea pig cerebellum membranes.
    Konkoy CS; Childers SR
    Mol Pharmacol; 1989 Oct; 36(4):627-33. PubMed ID: 2572962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein.
    Lawrence DM; Bidlack JM
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1678-83. PubMed ID: 8103800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the substitution of Phe4 in the opioid peptide [D-Ala8]dynorphin A-(1-11)NH2.
    Vig BS; Zheng MQ; Murray TF; Aldrich JV
    J Med Chem; 2003 Sep; 46(19):4002-8. PubMed ID: 12954053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coupling of the cloned rat kappa-opioid receptor to adenylyl cyclase is dependent on receptor expression.
    Hirst RA; Hirota K; Grandy DK; Lambert DG
    Neurosci Lett; 1997 Aug; 232(2):119-22. PubMed ID: 9302101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of arodyn, a novel acetylated dynorphin A-(1-11) analogue, as a kappa opioid receptor antagonist.
    Bennett MA; Murray TF; Aldrich JV
    J Med Chem; 2002 Dec; 45(26):5617-9. PubMed ID: 12477343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid receptor agonists activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase in canine cardiac sarcolemma.
    Niroomand F; Mura RA; Piacentini L; Kübler W
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):643-9. PubMed ID: 8938664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynorphin A-(1-13)-Tyr14-Leu15-Phe16-Asn17-Gly18-Pro19 : a potent and selective kappa opioid peptide.
    Martinka GP; Jhamandas K; Sabourin L; Lapierre C; Lemaire S
    Eur J Pharmacol; 1991 Apr; 196(2):161-7. PubMed ID: 1678718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Activity Relationships of the Peptide Kappa Opioid Receptor Antagonist Zyklophin.
    Joshi AA; Murray TF; Aldrich JV
    J Med Chem; 2015 Nov; 58(22):8783-95. PubMed ID: 26491810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential agonist regulation of the human kappa-opioid receptor.
    Blake AD; Bot G; Li S; Freeman JC; Reisine T
    J Neurochem; 1997 May; 68(5):1846-52. PubMed ID: 9109509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells.
    Hirota K; Okawa H; Appadu BL; Grandy DK; Devi LA; Lambert DG
    Anesthesiology; 1999 Jan; 90(1):174-82. PubMed ID: 9915326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioligand-dependent discrepancy in agonist affinities enhanced by mutations in the kappa-opioid receptor.
    Hjorth SA; Thirstrup K; Schwartz TW
    Mol Pharmacol; 1996 Oct; 50(4):977-84. PubMed ID: 8863844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nalpha-benzylTyr1,cyclo(D-Asp5,Dap8)]- dynorphin A-(1-11)NH2 cyclized in the "address" domain is a novel kappa-opioid receptor antagonist.
    Patkar KA; Yan X; Murray TF; Aldrich JV
    J Med Chem; 2005 Jul; 48(14):4500-3. PubMed ID: 15999987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activities of dynorphin A analogues with opioid antagonist properties.
    Gairin JE; Mazarguil H; Alvinerie P; Saint-Pierre S; Meunier JC; Cros J
    J Med Chem; 1986 Oct; 29(10):1913-7. PubMed ID: 2876099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity labelling of frog brain opioid receptors by dynorphin(1-10) chloromethyl ketone.
    Benyhe S; Ketevan A; Simon J; Hepp J; Medzihradszky K; Borsodi A
    Neuropeptides; 1997 Feb; 31(1):52-9. PubMed ID: 9574838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
    Puttfarcken PS; Werling LL; Cox BM
    Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.